SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-073382
Filing Date
2024-08-28
Accepted
2024-08-28 16:30:21
Documents
15
Period of Report
2024-08-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0212705-8k_aditxtinc.htm   iXBRL 8-K 42781
2 FORM OF WAIVER TO SENIOR NOTE ea021270501ex10-1_aditxtinc.htm EX-10.1 19232
3 FORM OF LETTER AGREEMENT ea021270501ex10-2_aditxtinc.htm EX-10.2 21848
  Complete submission text file 0001213900-24-073382.txt   268791

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adtx-20240822.xsd EX-101.SCH 3009
5 XBRL LABEL FILE adtx-20240822_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE adtx-20240822_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0212705-8k_aditxtinc_htm.xml XML 3784
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 241255919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)